Molecular profiling of Chinese R-CHOP treated DLBCL patients: Identifying a high-risk subgroup. Jiang S, Qin Y, Jiang H, Liu B, et al. Int J Cancer 2020;147:2611-2620.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Jiang S, Qin Y, Jiang H, Liu B, et al. Molecular profiling of Chinese R-CHOP treated DLBCL patients: Identifying a high-risk subgroup. Int J Cancer 2020;147:2611-2620.
PMID: 32399964